Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Exchange Rate Effect (2016 - 2025)

Ptc Therapeutics (PTCT) has 11 years of Exchange Rate Effect data on record, last reported at $9.8 million in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 213.2% year-over-year to $9.8 million; the TTM value through Dec 2025 reached $22.7 million, up 409.93%, while the annual FY2025 figure was $22.7 million, 409.93% up from the prior year.
  • Exchange Rate Effect reached $9.8 million in Q4 2025 per PTCT's latest filing, up from -$6.1 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $13.6 million in Q2 2025 and bottomed at -$12.1 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is $395250.0, with a median of -$24000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: crashed 57514.29% in 2021, then skyrocketed 508.85% in 2023.
  • A 5-year view of Exchange Rate Effect shows it stood at -$3.9 million in 2021, then soared by 254.84% to $6.0 million in 2022, then crashed by 48.59% to $3.1 million in 2023, then tumbled by 379.58% to -$8.7 million in 2024, then skyrocketed by 213.2% to $9.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $9.8 million in Q4 2025, -$6.1 million in Q3 2025, and $13.6 million in Q2 2025.